斑点作为心脏病性休克的预后标志物
Hamid Merdji1, Vincent Bataille2, Anais Curtiaud1
1Faculté de Médecine, Strasbourg University Hospital, Nouvel Hôpital Civil, Medical Intensive Care Unit, Université de Strasbourg (UNISTRA), Strasbourg, France.
Annals of intensive care
|September 6, 2023
概括
心脏性休克患者的皮肤斑点表明长时间住院的风险更高,死亡率增加. 这种简单的临床标志可以指导即时的目标导向治疗,以改善患者的治疗结果.
科学领域:
- 关键护理医学 关键护理医学
- 心脏病学 心脏病学
- 临床生理学 临床生理学
背景情况:
- 皮肤斑点是心脏病性休克的一个研究不足的指标.
- 预后因素的早期识别对于管理心脏性休克至关重要.
研究的目的:
- 调查皮肤斑点对心脏性休克患者结果的影响.
- 确定短期 (30天) 和长期 (1年) 死亡率的决定因素.
主要方法:
- 法国重症监护单位的前性多中心观察注册 (FRENSHOCK).
- 招募了772名心脏性休克患者,在入院时评估了皮肤斑点.
- 分析了斑点与需要呼吸/脏支持,机械循环支持,停留时间和死亡率之间的关联.
主要成果:
- 39%的患者在入院时表现出皮肤斑点.
- 化与侵入性呼吸辅助 (50.2%对30.1%) 和置换疗法 (19.9%对12.4%) 的需求增加有关.
- 斑点患者的30天死亡率 (31%对23.3%) 和1年死亡率 (54%对42%) 较高.
结论:
- 入院时的皮肤斑点是长时间住院和心脏性休克不良结果的重要预测因素.
- 模糊作为一个简单的,临床 perfusion 参数,以指导立即的目标导向治疗.
- 使用斑点评估可能会改善心脏病性休克患者的管理和结果.
相关概念视频
Mitral Stenosis II: Clinical features and Diagnostic Tests
22
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
22
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
22
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
22
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16


